Development and validation of a collagen signature to predict central lymph node metastasis in papillary thyroid cancer
The collagen signature within the TME represents a promising new biomarker that can effectively predict CLNM in PTC patients, potentially improving clinical decision-making and patient management.
Authors
- Wei‐Sheng Chen (ORCID: https://orcid.org/0000-0001-8672-180X)
- Shangtong Lei (ORCID: https://orcid.org/0000-0002-2014-3813)
- Cangui Wu
- Tingyue Luo
- B. Ye
- Dongling Zhang (ORCID: https://orcid.org/0000-0003-2535-1897)
- Shumin Dong
- Wenle He (ORCID: https://orcid.org/0009-0004-7627-1680)
- Jun Yan (ORCID: https://orcid.org/0000-0002-9190-6777)
- Wei Jiang (ORCID: https://orcid.org/0000-0001-6263-0516)
- Jun-Na Ge
Institutions
- First Affiliated Hospital of Zhengzhou University (CN)
- Southern Medical University (CN)
Publication Details
- Journal
- Frontiers in Endocrinology
- Published
- 2025-11-28
- DOI
- https://doi.org/10.3389/fendo.2025.1691788
- Primary Topic
- Thyroid Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China
- Southern Medical University
- Nanfang Hospital
- National Science and Technology Major Project